Similar articles

• Polyamines in mammalian tumors. Part I.

  Scalabrino G, Ferioli ME. Scalabrino G, et al. Adv Cancer Res. 1981;35:151-268. doi: 10.1016/s0065-230x(08)60911-2. Adv Cancer Res. 1981. PMID: 7041538 Review. No abstract available.
• The relationship between levels and rates of synthesis of polyamines during mammalian cell cycle.

  Sunkara PS, Ramakrishna S, Nishioka K, Rao PN. Sunkara PS, et al. Life Sci. 1981 Mar 30;28(13):1497-506. doi: 10.1016/0024-3205(81)90382-9. Life Sci. 1981. PMID: 6787355 No abstract available.
• Several inhibitors of ornithine and adenosylmethionine decarboxylases may also have antiproliferative effects unrelated to polyamine depletion.

  Hölttä E, Korpela H, Hovi T. Hölttä E, et al. Biochim Biophys Acta. 1981 Sep 18;677(1):90-102. doi: 10.1016/0304-4165(81)90149-5. Biochim Biophys Acta. 1981. PMID: 6794647 No abstract available.
• Aspects of the biochemical pharmacology of methyl glyoxal bis(guanylhydrazone).

  Williams-Ashman HG, Seidenfeld J. Williams-Ashman HG, et al. Biochem Pharmacol. 1986 Apr 15;35(8):1217-25. doi: 10.1016/0006-2952(86)90263-7. Biochem Pharmacol. 1986. PMID: 3083820 Review. No abstract available.
• Polyamines as targets for therapeutic intervention.

  Marton LJ, Pegg AE. Marton LJ, et al. Annu Rev Pharmacol Toxicol. 1995;35:55-91. doi: 10.1146/annurev.pa.35.040195.000415. Annu Rev Pharmacol Toxicol. 1995. PMID: 7598507 Review.